BIIB

NASDAQ

Biogen, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$28.25B

PE Ratio

20.3129

EV to Ebitda

9.7724

Earnings Yield

4.92%

Revenue (TTM)

$9.60B

Net Income (TTM)

$1.37B

Revenue (Annual YoY Growth)

2.88%

Revenue (Quarterly YoY Growth)

2.88%

Profit Margin

14.29%

Return on Equity

7.64%

Debt to Equity Ratio

0.3518

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$28.25B

Revenue TTM$9.60B

Shares Outstanding147.6M

Float144426545

Float Short2.99%

Days To Cover3.5740301273

Short Interest4370891.0

Insider Ownership1.67%

Relative Strength79.7

GARP2186

Growth Estimates16 fields›

Revenue Growth (Annual)2.88%

Revenue Growth (Quarterly YoY)2.88%

Operating Revenue Growth (Quarterly YoY)-0.037807

3-Year Revenue Growth0.35%

5-Year Revenue Growth-5.06%

EPS Growth (Annual)-21.43%

EPS Growth (Quarterly YoY)31.24%

3-Year EPS Growth Rate-25.04%

5-Year EPS Growth Rate-18.74%

LT EPS Growth Estimates3.61%

EBITDA Growth (Annual)18.83%

EBITDA Growth (Quarterly YoY)-13.95%

CFO Growth (Annual)-23.33%

CFO Growth (Quarterly YoY)148.94%

FCF Growth (Annual)-21.72%

FCF Growth (Quarterly YoY)163.57%

Operations28 fields›

Revenue TTM$9.60B

Gross Margin TTM66.29%

Gross Margin (Quarterly)63.99%

R&D % of Revenue TTM16.74%

R&D Expenses TTM$1.61B

Operating Margin TTM23.87%

Operating Margin (Quarterly)19.12%

Operating Expenses TTM$4.07B

Profit Margin TTM14.29%

Profit Margin (Quarterly)13.29%

Net Income TTM$1.37B

EPS TTM9.3182

EPS (Quarterly)2.153

EBIT Margin TTM23.87%

EBIT Margin (Quarterly)19.12%

EBITDA Margin TTM32.22%

EBITDA Margin (Quarterly)27.62%

EBITDA TTM$3.09B

CFO % of Revenue TTM23.13%

CFO % of Revenue (Quarterly)26.86%

CFO TTM$2.59B

Cash Margin21.26%

Capex % of Revenue TTM2.86%

Capital Expenditures$274.5M

FCF % of Revenue TTM20.66%

FCF % of Revenue (Quarterly)23.27%

FCF TTM$2.32B

Fundamental Score6

Efficiency6 fields›

ROE7.64%

ROA4.75%

ROIC5.59%

CROCI9.43%

Stock Comp % (Quarterly)3.50%

Stock Comp % TTM3.05%

Valuation19 fields›

P/E (TTM)20.3129

P/E Forward13.9671

P/E Ex-Cash17.1999

P/S Forward2.7965

PEG Forward0.2578

P/CFO10.756

P/FCF12.0307

EV/EBITDA (TTM)9.7724

EV/EBITDA Forward8.9896

EV/Revenues (TTM)3.1482

EV/Revenues Forward3.0246

EV/CFO11.3242

EV/FCF (TTM)13.0484

Price To Book1.4982

Price to Tangible Book8.7713

Earnings Yield4.92%

FCF Yield8.31%

Dividend Yield0.00%

Value Score4

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)0.8997

Relative Profit Margin (Quarterly)1.01

Relative P/E0.827

Relative P/S0.6166

Relative P/B0.2369

Relative Earnings Yield1.2092

Relative Dividend Yield0

Relative ROE0.2586

Relative ROA0.492

Relative ROIC0.3795

Relative Debt to Equity0.3562

Liquidity15 fields›

Cash Per Share29.0156

Current Ratio3.0646

Cash & ST Assets$4.28B

Total Debt$6.56B

Goodwill & Intangibles$15.54B

Total Assets$29.48B

Total Liabilities$10.83B

Shareholders Equity$18.65B

Debt to Equity0.3518

Debt to Assets22.26%

Interest Expense$275.1M

Times Interest Earned8.3304

CFO to Debt (TTM)0.3922

Debt to EBITDA (TTM)2.1356

Goodwill % of Assets52.72%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield4.92%

Buyback Yield0.15%

Shareholder Yield0.27%

Options Flow8 fields›

Call Volume703

Put Volume780

Put/Call Ratio1.1095305832147937

Call $ Volume863501

Put $ Volume341847

Put/Call $ Ratio0.39588489185304937

Call OI29172

Put OI24784